mibefradil has been researched along with charybdotoxin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Earm, YE; Kang, TM; Kim, SJ; Nam, JH; Nguyen, YH; Yoo, HY; Zheng, H | 1 |
1 other study(ies) available for mibefradil and charybdotoxin
| Article | Year |
|---|---|
Facilitation of Ca2+-activated K+ channels (IKCa1) by mibefradil in B lymphocytes.
Topics: Animals; B-Lymphocytes; Calcium; Calcium Channel Blockers; Cell Line; Charybdotoxin; Dose-Response Relationship, Drug; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Lymphocyte Activation; Membrane Potentials; Membrane Transport Modulators; Mibefradil; Mice; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Transfection | 2008 |